癌における細胞外膀の役割
Raghu Kalluri1, Kathleen M McAndrews1
1Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Cell
|April 14, 2023
まとめ
細胞外膀 (EVs) は,がんの細胞間コミュニケーションを介し,進行と転移に影響を与えます. このレビューは,がんの生物学における,バイオマーカーとしての,そして治療開発におけるその役割をカバーしています.
科学分野:
- 腫瘍学
- 細胞生物学
- 生物化学
背景:
- 細胞間通信は 癌の進行と転移に不可欠です
- 細胞外膀 (EV) は,生物活性分子を転送する,このコミュニケーションの鍵となる媒介体です.
- EVは癌細胞と腫瘍の微小環境に影響します
研究 の 目的:
- 癌におけるEVの機能的役割の理解における最近の進歩をレビューする.
- 癌のバイオマーカーとしてEVの応用を探る
- EVベースのがん治療法の開発について議論する.
主な方法:
- 癌における細胞外膀に関する最近の研究の文献レビュー.
- 癌の進行と転移に対するEVの機能的貢献の分析
- 潜在的な癌バイオマーカーと治療薬としてのEVの評価
主要な成果:
- EVは癌細胞の伝達を促進する上で重要な役割を果たします.
- EVは癌の進行と転移を促進します.
- EVは 診断用バイオマーカーと 治療用輸送手段として有望です
結論:
- 細胞外膀は癌の生物学において 重要な役割を果たします
- EVに関するさらなる研究は,がんの新たな診断と治療戦略につながる可能性があります.
- EVの機能を理解することは 癌治療の進歩に不可欠です
関連する概念動画
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


